ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The biobased chemicals developer Verdezyne has reached an agreement with Bio-XCell Malaysia, a biotech industrial park, to build what it says will be the world’s first plant to produce biobased dodecanedioic acid (DDDA) and other diacids. To be built with a $75 million loan from Bio-XCell, the plant is set to have annual diacids capacity of 30 million lb. DDDA is used to manufacture specialty nylons. Verdezyne says its yeast fermentation process can convert nonfood, plant-based feedstocks into diacids at lower cost than traditional petrochemical routes.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter